Newsroom

MIAMI--(BUSINESS WIRE)--QAD | Redzone, the company behind the world’s number one platform for manufacturers, today announced that QAD has been recognized as a Major Player in the IDC MarketScape for Worldwide AI-Enabled Direct Spend 2026 Vendor Assessment (#US54900426, September 2026).QAD SRM is a supplier relationship management solution built for manufacturers that is compatible with any ERP. It supports strategic direct materials sourcing, where decisions are made years ahead of production: m...

NEW YORK--(BUSINESS WIRE)--Kontakt.io introduces KIO Clinic to bring a unified approach to outpatient operations...

OTTAWA, Ontario & LONDON--(BUSINESS WIRE)--MindBridge Analytics Inc., which provides the intelligence layer for Augmented Assurance, and Validis, a leading provider of financial data collection and standardization technology, announced a partnership and integration that sends standardized client data from Validis directly into MindBridge for full-population risk analysis. Audit analytics work begins with getting client data out of accounting systems and into a usable form. That work comes befor...

ZURICH--(BUSINESS WIRE)--Rivia Expands Clinical Trial Intelligence Platform with New AI-Powered Data Findings Module...

NEW YORK--(BUSINESS WIRE)--RALPH LAUREN REPORTS SECOND QUARTER FISCAL 2027 RESULTS AHEAD OF EXPECTATIONS AND RAISES FISCAL 2027 OUTLOOK...

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a healthcare information technology company providing AI-enabled revenue cycle management and related technology to diagnostic laboratories, pathology groups, radiology practices, hospital outreach programs, and pharmacies, today announced that the XiFin®Empower RCM System has achieved HITRUST Risk-based, 2-year (r2) Certified status for the third consecutive two-year term. XiFin also announced that its Pharmacy Documentation and Workflow System, Clinical...

PHOENIX--(BUSINESS WIRE)--Centuri Holdings, Inc. (NYSE: CTRI) ("Centuri" or the "Company") today announced financial and operating results for the third quarter ended September 27, 2026. Third Quarter 2026 Results and Highlights Achieved company record quarterly Revenue of $1.2 billion, a 40% increase versus the third quarter of 2025 Produced record quarterly Gross Profit of $113.4 million, a 45% increase from the same period last year Delivered a Gross Profit margin of 9.5%, up from 9.2% in th...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today announced that it will report its third quarter 2026 financial and operating results on November 12, 2026, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on November 12, 2026, at 4:30 p.m. Eastern Time/1:...

PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics today announced that the Company will participate at the following investor conferences: Stifel 2026 Healthcare Conference. The Company will attend on Thursday, November 12, and will provide a corporate presentation at 9:20 a.m. – 9:50 a.m. ET. Jefferies 2026 Global Healthcare Conference in London. The Company will attend and participate in one-on-one meetings from Monday, November 16 – Wednesday, November 18. Management will host and particip...

NEW YORK, NY--(BUSINESS WIRE)--USA TODAY Co., Inc. ("USA TODAY Co.", "we", "us", "our", or the "Company") (NYSE: TDAY) today reported its financial results for the third quarter ended September 30, 2026. "In the third quarter, we felt the impacts of the changes in consumer search along with some inflationary pressures. At the same time, we saw encouraging underlying signals in the categories that we believe are most important to our future. Audience trends showed signs of stabilization, engagem...